Arkolith/Insider Trading/AMAM/Form 4

Darwin Global Management, Ltd.

10% OwnerAmbrx Biopharma Inc. (AMAM) · full profile →Form 4 · filed Mar 8, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 6, 2023Buy(P)3.6M$6.50$23.5M11.3M
Feb 28, 2023Buy(P)40K$6.02$241K7.7M
Feb 27, 2023Buy(P)65K$5.48$357K7.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-23-002156) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML